MedPath

Cougar Biotechnology, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

Phase 2
Completed
Conditions
Prostate Neoplasms
Interventions
First Posted Date
2007-05-16
Last Posted Date
2014-05-12
Lead Sponsor
Cougar Biotechnology, Inc.
Target Recruit Count
47
Registration Number
NCT00474383

A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy

Phase 1
Completed
Conditions
Prostatic Neoplasms
Interventions
First Posted Date
2007-05-15
Last Posted Date
2014-03-27
Lead Sponsor
Cougar Biotechnology, Inc.
Target Recruit Count
54
Registration Number
NCT00473512
© Copyright 2025. All Rights Reserved by MedPath